complications in this investigation include (1) competing
intramolecular cyclopropanation,10 (2) competing alkene
migration,11 and (3) a slower intramolecular DielsꢀAlder
event, thus allowing for competing isobenzofuran
decomposition.
this reaction for the preparation of the more challenging
seven-membered ring systems is investigated.
Scheme 2
Scheme 1
Alkene-containing carbene complexes (1 and 2, Scheme 2)
were synthesized from known or commercially available
compounds according to the Fischer synthetic routes de-
picted in Scheme 2. The organolithium reagents were gener-
ated through reaction of the bromides with lithium metal
wherever possible due to safety concerns. In more sluggish
cases, lithiation of the iodide with tert-butyllithium was
employed. Competing Bailey cyclization of the organo-
lithium intermediates16 was not a problem under the condi-
tions employed. The aryl-tethered carbene complexes were
prepared from 2-bromobenzyl bromide through halogen
ꢀmetal exchange followed by analogous conversion to the
carbene complex. Compound 2a was a very unstable com-
pound and had to be used immediately after its synthesis.
The first reaction examined was the coupling of alky-
nylbenzophenone derivative 5a (Scheme 3) with carbene
complex 1a. The benzophenone derivative 5a had proven
to be the most reliable substrate in related [5 þ 5]-cycload-
dition processes17 owing to the enhanced stability of
arylisobenzofuran intermediates. After treatment of the
crude reaction mixture with aqueous HCl, the naphthalene
derivative 7a was isolated in 77% yield. The more challen-
ging reaction, coupling of complex 1a alkynylbenzalde-
hyde derivative 5b, was examined under a variety of
conditions. Thermolysis in dioxane followed by treatment
with acid led to naphthocycloheptanone 7b in 73% yield.
As noted in previous manuscripts, addition of water17 or
collidine1 to [5 þ 5]-cycloaddition reactions often led to
improved yields of adducts. Addition of either of these
additives led to uncyclized compounds tentatively assigned
asalkylidenephthalans (8b/9b), which result from a net 1,7-
hydride shift of the vinylisobenzofuran intermediate7 and
were often produced when a carbene complex incapable
of the DielsꢀAlder step was employed.18 In related
The coupling of δ,ε-unsaturated carbene complexes
(B, n = 2) and alkynylbenzaldehydes would hypothetically
lead to seven-membered rings fused to a naphthalene ring
system (F, n = 2). Benzo-fused cycloheptanones and their
simple derivatives are a very important structural feature
in numerous medicinal compounds, including the anti-
HIV drug TAK-779,12 intermediates for colchicine syn-
thesis,13 numerous experimental anticancer drugs,14 and
treatments for neurodegenerative disorders.15 The title
reaction is a two-component coupling where a diverse
array of synthetic routes exists for both of the coupling
partners. The basic coupling process is an intermolecular
coupling requiring no preorganization of the reactants and
thus is inherently versatile compared to any process limited
to intramolecular systems. In this manuscript, the use of
(10) (a) Alvarez-Toledano, C.; Rudler, H.; Daran, J. C.; Jeannin, Y.
€
Chem. Commun. 1984, 574–576. (b) Soderberg, B. C.; Hegedus, L. S.
Organometallics 1990, 9, 3113–3121.
(11) Alvarez-Toledano, C.; Parlier, A.; Rudler, H.; Rudler, M.;
Daran, J. C.; Knobler, C.; Jeannin, Y. J. Organomet. Chem. 1987, 328,
357–373.
(12) (a) Baba, M.; Nishimura, O.; Kanzaki, N.; Okamoto, M.;
Sawada, H.; Izawa, Y.; Shiraishi, M.; Arakami, Y.; Okonogi, K.;
Ogawa, Y.; Meguro, K.; Fujino, M. Proc. Natl. Acad. Sci. U.S.A.
1999, 96, 5698–5703. (b) Westby, M.; van der Ryst, E. Antiviral
Chemistry and Chemotherapy 2005, 16, 339–354.
(13) van Tamelen, E. E.; Spencer, T. A., Jr.; Allen, D. S., Jr.; Orvis,
R. L. J. Am. Chem. Soc. 1959, 81, 6341–6342.
(14) (a) Sriram, M; Hall, J. J.; Grohmann, N. C.; Strecker, T. E.;
Wootton, T.; Franken, A.; Trawick, M. L.; Pinney, K. G. Bioorg. Med.
Chem. 2008, 16, 8161–8171. (b) Tarnus, R. C.; Defoin, A.; Albrecht, S.;
Maiereanu, A.; Faux, N.; Pale, P.; Fr. Demande (2008), FR 2908131 A1
20080509.
(15) (a) Chen, Y. L. ; Zhang, L. PCT Int. Appl. 2005 Coden: PIXXD2.
(b) Satoh, Y.; Hatori, C.; Ito, H. Bioorg. Med. Chem. Lett. 2002, 12, 1009–
1011. (c) Itani, H.; Ito, H.; Sakata, Y.; Hatakeyama, Y.; Oohashi, H.;
Satoh, Y. Bioorg. Med. Chem. Lett. 2002, 12, 799–802. (d) Liu, Y.;
(16) Bailey, W. F.; Nurmi, T. T.; Patricia, J. J.; Wang, W. J. Am.
Chem. Soc. 1987, 109, 2442–2448.
(17) Li, R.; Camacho-Davila, A.; Herndon, J. W. Tetrahedron Lett.
€
€
Mellin, C.; Bjork, L.; Svensson, B; Csoregh, I.; Helander, A.; Kenne, L.;
2005, 46, 5117–5120.
ꢀ
Anden, N. E.; Hacksell, U. J. Med. Chem. 1989, 32, 2311–2318. (e)
Hacksell, U.; Arvidsson, L. E.; Svensson, U.; Nilsson, J. L. G.;
(18) (a) Jiang, D.; Herndon, J. W. Org. Lett. 2000, 2, 1267–1269. (b)
Duan, S.; Cress, K.; Waynant, K.; Ramos-Miranda, E.; Herndon, J. W.
Tetrahedron 2007, 63, 2959–2965.
€
Wikstrom, H.; Lindberg, P.; Sanchez, D.; Hjorth, S.; Carlsson, A.;
Paalzow, L. J. Med. Chem. 1981, 24, 429–434.
Org. Lett., Vol. 13, No. 11, 2011
2849